Search results for "Side effects"
Hydrochlorothiazide no better than placebo for preventing kidney stone recurrence
A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
https://immattersacp.org/weekly/archives/2023/03/07/1.htm
7 Mar 2023
Pressing forward with primary prevention for CVD
This issue includes stories on managing cardiovascular disease, prescribing benzodiazepines, and diagnosing depression in the elderly.
https://immattersacp.org/archives/2022/02/pressing-forward-with-primary-prevention-for-cvd.htm
1 Feb 2022
Warning on steroids; approval for soft-tissue sarcoma drug
This column reviews a warning on testosterone and other anabolic androgenic steroids and approval of a new drug to treat certain adults with soft-tissue sarcoma.
https://immattersacp.org/archives/2017/01/fda-update.htm
1 Jan 2017
New warnings added on multiple diabetes drugs
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
https://immattersacp.org/archives/2015/11/fda.htm
1 Nov 2015
Details debated in breast screening
Amid a thicket of competing and sometimes conflicting studies about breast cancer screening, medical groups have adopted differing stances on how to address the conundrum of harms versus benefits.
https://immattersacp.org/archives/2017/03/breast-screening.htm
1 Mar 2017
Warning on NSAIDs; new schizophrenia drug approved
This update covers a strengthened warning on NSAIDs and a new drug to treat schizophrenia.
https://immattersacp.org/archives/2015/09/fda.htm
1 Sep 2015
No interventions proven to prevent late-life dementia, systematic reviews find
The reviews examined physical activity, prescription medications, cognitive training, and over-the-counter vitamins and supplements.
https://immattersacp.org/weekly/archives/2017/12/19/1.htm
19 Dec 2017
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015
MKSAP Quiz: Evaluation for primary hyperparathyroidism
A 67-year-old man is evaluated for a recent diagnosis of primary hyperparathyroidism after an elevated serum calcium level was incidentally detected on laboratory testing. Medical history is significant only for hypertension, and his only medication is ramipril. Following a physical exam and lab studies, what is the most appropriate management of this patient?
https://immattersacp.org/weekly/archives/2017/02/14/3.htm
14 Feb 2017
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015